ALERS.PA
BuyPremium GrowerFLAGEurobio Scientific Société anonyme · Healthcare · France · $233M · Avg Vol: $17K/d
Premium Grower: Strong business with the market behind it, but you are paying up for it.
Insufficient evidence for a screen-pass. Eurobio Scientific Société anonyme: clears the 50 floor (Q58/V57/M52) but not the 60 strong bar, and carries no corroborating filing signal (no net insider buying, no active buyback). Absence of evidence is neutral; nothing adverse is known.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT EUROBIO SCIENTIFIC SOCIÉTÉ ANONYME
Read
Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences.
FINANCIAL SUMMARY (EUR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 152.6M | 130.0M | 154.6M | 168.6M | 3.4% | 168.4M | 176.5M | 4.7% |
| EPS (EUR) | 2.20 | 0.43 | 0.39 | 0.47 | -40.2% | 0.47 | 0.52 | 10.4% |
| Shares | 10.2M | 10.0M | 10.0M | 10.1M | -1.5% | 10.1M | — | — |
| Debt | 114.3M | 101.3M | 34.1M | 16.0M | -48.1% | 16.0M | — | — |
| Equity | 173.0M | 175.2M | 178.9M | 183.9M | 2.1% | — | — | — |
| Op CF | 43.1M | 26.8M | 16.7M | 18.9M | -24.1% | 18.8M | — | — |
| Inv CF | -141.8M | -0.3M | -10.7M | -12.9M | — | — | — | — |
| Fin CF | 82.3M | -23.5M | -72.1M | -8.2M | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALERS.PA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ALERS.PA | Eurobio Scientific Société anonyme(you) | $233M | 69 | Buy |
| GBT.PA | Guerbet SA | $112M | 59 | Hold |
| NCYT.L | Novacyt S.A. | $42M | 54 | Hold |
| ALMDT.PA | Median Technologies SA | $253M | 12 | Strong Sell |
| ALTHE.PA | Theraclion SA | $57M | 20 | Sell |
| BLC.PA | Bastide Le Confort Médical SA | $186M | 96 | Strong Buy |
| LBIRD.PA | Lumibird SA | $651M | 82 | Strong Buy |
| LNA.PA | LNA Santé SA | $397M | 96 | Strong Buy |
| BOI.PA | Boiron SA | $509M | 99 | Strong Buy |
| CLARI.PA | Clariane SE | $1.6B | 79 | Buy |
Peer medians: ROE -42.5% · P/E 22.9x · Gross margin 73.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.